Asia Pacific accounted for 45.42% of global dodder seeds revenue in 2025, worth USD 28.39 million, more than the next four regions combined. Contrive Datum Insights has published "Dodder Seeds Market Size, Share & Industry Analysis, By Type (Chinese Dodder Seed, Australian Dodder Seed, California Dodder Seed), Application (Herbal Medicine, Dietary Supplements, Personal Care and Cosmetics), Form (Whole/Raw Seed, Powder and Extract, Seed Oil), Distribution channel (Direct/B2B Trade, Pharmacies and Health Stores, Online Retail), End user (Nutraceutical and Pharmaceutical Manufacturers, Traditional Medicine Practitioners and Individual Consumers, Cosmetics and Personal Care Manufacturers), and Regional Forecast, 2026-2034".
The global market is sized at USD 62.5 million in 2025. The study projects USD 66.8 million in 2026, rising to USD 121.79 million by 2034 at a compound annual growth rate of 7.8%.
No other region approaches Asia Pacific's scale. China alone accounts for USD 15.61 million of 2025 revenue, 24.98% of the global total, more than any other single country market. Middle East and Africa sits at the opposite end of the table: 6% of 2025 revenue, and the study holds it at 6% through 2034, the only region whose share does not move over the forecast period. Asia Pacific's own share does move, climbing from 45.42% in 2025 to 48% in 2034 as its revenue grows to USD 58.46 million.
Demand is broad-based, not concentrated in one segment
Herbal Medicine is the largest application, 47.98% of 2025 revenue at USD 29.99 million, but Dietary Supplements grows faster, at 9.3% a year. Whole/Raw Seed leads by form, 44.99% of 2025 revenue, while Seed Oil compounds at 9.19%. Direct/B2B Trade still carries half of 2025 revenue, yet Online Retail is the fastest-growing channel in the study at 12.66%. Traditional Medicine Practitioners and Individual Consumers make up the largest end-user group at 42% of 2025 revenue; Nutraceutical and Pharmaceutical Manufacturers grow fastest among end users, at 9.11%. On type, Chinese Dodder Seed supplies 62.5% of 2025 revenue and stays largest through 2034 at 58% of the total, while California Dodder Seed grows at 9.9%, taking its own share from 16.78% to 20% and its revenue from USD 10.49 million to USD 24.36 million.
A faster shift away from single-origin supply would cut into Asia Pacific's edge
The study's bull scenario assumes supplement and cosmetics formulators adopt standardized dodder seed extract faster, and that cultivation outside China scales more quickly to reduce reliance on a single origin; under those conditions 2034 revenue reaches USD 141.47 million instead of USD 121.79 million. That second assumption cuts against the region that benefits most from concentrated supply today. The bear scenario points the other way: tighter import compliance in key supplement-importing markets and slower cultivation growth outside China would hold 2034 revenue to USD 103.84 million, an outcome that keeps existing supply patterns, and Asia Pacific's position with them, largely intact.
The report covers all five regions with country-level detail, five segmentation axes with revenue and growth for every line from 2020 to 2034, the competitive landscape, and the methodology behind each estimate. It is delivered as a PDF; a free sample is available on request.